Institute News

On March 26, 1949, the Fraunhofer-Gesellschaft was founded in Munich as a non-profit organization. Three quarters of a century later, it is one of the world's leading organizations for application-oriented research with more than 30,000 employees and 76 institutes not only in Germany but also in other parts of the world. They are all united by one guiding principle: to develop innovations for the future from ideas.

DMEA, Europe's leading event for digital health, brings together exhibitors and industry experts from 9 to 11 April 2024 to present and discuss the latest developments, technologies and solutions for digitalization in healthcare. Our experts look forward to seeing you at the Fraunhofer stand, Hall 2.2, Stand D-108.

The potential benefits of using AI technology in healthcare are enormous. However, there are significant practical, technological, and legal implications that must be considered to protect patients. The BOX is an interactive installation that explores the “black box” aspect of AI technology, posing the question: If we feed AI with incomplete or biased data - can we then expect it to make reasonable suggestions?

Fraunhofer MEVIS aims for utilizing compact MRI devices for research and education. Lecture “MRI Sequence Composition Beyond Academia” and workshop “Prototype your own MRI Sequence,” 4th of April, in cooperation with the Institute for Design Informatics (IDI), University of Edinburgh.

The aim of the BVM Workshop 2024 (German Conference on Medical Image Computing), which takes place in Erlangen from March 10 to 12, is to exchange current research results and to facilitate in-depth discussions among scientists, industry, and users from medicine and technology. The workshop offers young scientists in particular a platform to present their work.

The Fraunhofer MEVIS institute building on the campus of the University of Bremen has been retrofitted with a photovoltaic system, which has now gone into operation. As was previously the case with the commissioning of five charging points for electromobility, Fraunhofer MEVIS is thus making a contribution to reducing its ecological footprint and strengthening sustainability.

Artificial intelligence and computer-aided support for diagnosis and therapy in digital medicine—these are the topics Fraunhofer MEVIS is presenting at the International Society for Optics and Photonics (SPIE) Medical Imaging conference, which is held in San Diego, California, from February 18 to 22. This year, the Fraunhofer Institute for Digital Medicine MEVIS is again well represented at the renowned conference with numerous scientific and educational contributions.

Conclusion of an innovative art, science, and technology collaboration on the human body by the artist collective Marshmallow Laser Feast and Fraunhofer MEVIS.

Prof. Dr. med. Fabian Kiessling has been recognized by Clarivate as a Highly Cited Researcher 2023 in the Pharmacology and Toxicology category. This is the fifth consecutive year he has been on the Highly Cited Researcher list, having already been recognized in the same category in 2022 and 2021 as well as in the Cross-Field category in 2019 and 2020.

At this year’s annual RSNA meeting (Radiological Society of North America) in Chicago, Fraunhofer MEVIS presents, among others, the following promising innovations for AI-supported medicine: SATORI which helps to conduct multicenter studies and OncoChange which supports the follow-up of tumor treatments.